Aimed at an audience of undergraduate students to professionals in the fields of genomics and cancer, the symposium will provide an opportunity for academics and representatives from industry to connect and have open discussions about the field of oncogenomics and its impact on clinical care. The symposium’s first day will consist of an industry technical showcase by PerkinElmer, DNANexus, and Qiagen. The second day will include talks by various academics and industry professionals followed by a tour of the Facility for Rare Isotope Beams. “This year we hope to extend our research further, build durable corporate and clinical partnerships and break down the health and medicine barriers that limit us from ensuring 100 years of health for 100 percent of our population. These objectives will enhance our research mission that extends 'From first ever... to first in humans,' said Chris Contag, director of the Institute of Quantitative Health Science and Engineering. Registration for the event is free, but required in order to attend. Go to the EventBrite site to register. Related Website: Story courtesy of MSUToday. Communications contact: Patricia Mroczek

中文翻译：

---

精准肿瘤学

该研讨会面向本科生和基因组学和癌症领域的专业人士，将为学术界和行业代表提供一个机会，就致癌基因组学领域及其对临床护理的影响进行交流和公开讨论。研讨会的第一天将包括 PerkinElmer、DNANexus 和 Qiagen 的行业技术展示。第二天将包括各种学者和行业专业人士的演讲，然后参观稀有同位素束设施。“今年我们希望进一步扩展我们的研究，建立持久的企业和临床合作伙伴关系，并打破限制我们确保 100% 人口 100 年健康的健康和医学障碍。这些目标将增强我们的研究使命，扩展“ 定量健康科学与工程研究所所长克里斯康塔格说，从有史以来第一次……到人类中的第一个。该活动的注册是免费的，但必须参加才能参加。前往 EventBrite 网站进行注册。相关网站：故事由 MSUToday 提供。通讯联络人：Patricia Mroczek